pmc.ncbi.nlm.nih.gov

Placebo mania. Placebo controlled trials are needed to provide data on effectiveness of active treatment

1008

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Double D. B. Unblinding in trials of the withdrawal of anticholinergic agents in patients maintained on neuroleptics. J Nerv Ment Dis. 1995 Sep;183(9):599–602. doi: 10.1097/00005053-199509000-00007. [DOI] [PubMed] [Google Scholar]
  2. Fisher S., Greenberg R. P. How sound is the double-blind design for evaluating psychotropic drugs? J Nerv Ment Dis. 1993 Jun;181(6):345–350. doi: 10.1097/00005053-199306000-00002. [DOI] [PubMed] [Google Scholar]
  3. ROZEBOOM W. W. The fallacy of the null-hypothesis significance test. Psychol Bull. 1960 Sep;57:416–428. doi: 10.1037/h0042040. [DOI] [PubMed] [Google Scholar]
  4. Rothman K. J. Placebo mania. BMJ. 1996 Jul 6;313(7048):3–4. doi: 10.1136/bmj.313.7048.3a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Wechsler H., Grosser G. H., Greenblatt M. Research evaluating antidepressant medications on hospitalized mental patients: a survey of published reports during a five-year period. J Nerv Ment Dis. 1965 Aug;141(2):231–239. doi: 10.1097/00005053-196508000-00012. [DOI] [PubMed] [Google Scholar]